SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 63,844 | -- | -- | 37% 174.38K to 238.22K | |
07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 220,496 | -- | -- | 93% 238.22K to 458.72K | |
07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 71,303 | -- | -- | 16% 458.72K to 530.02K | |
11-Mar-20 5:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 52,842 | -- | -- | (15%) 353.37K to 300.53K | |
11-Mar-20 5:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 182,500 | -- | -- | (61%) 300.53K to 118.03K | |
11-Mar-20 5:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 59,016 | -- | -- | (50%) 118.03K to 59.02K | |
11-Mar-20 5:57 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 31,303 | -- | -- | 100% 0 to 31.3K | |
11-Mar-20 5:57 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 108,113 | -- | -- | 345% 31.3K to 139.42K | |
11-Mar-20 5:57 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 34,960 | -- | -- | 25% 139.42K to 174.38K | |
03-Mar-20 4:32 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 27-Feb-20 | Grant | 42,493 | -- | -- | 17% 251.87K to 294.36K | |
05-Nov-19 4:32 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 04-Nov-19 | Option Exercise | 32,500 | $0.62 | $20,150.00 | 15% 219.37K to 251.87K | |
17-Oct-19 4:11 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 15-Oct-19 | Option Exercise | 90,000 | $0.62 | $55,800.00 | 70% 129.37K to 219.37K | |
14-Aug-19 2:59 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 13-Aug-19 | Option Exercise | 60,000 | $0.62 | $37,200.00 | 86% 69.36K to 129.37K | |
20-May-19 6:34 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 16-May-19 | Grant | 56,391 | -- | -- | 435% 12.97K to 69.36K | |
13-Jul-18 4:08 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 13-Jul-18 | Option Exercise | 1,616 | -- | -- | 14% 11.36K to 12.97K | |
31-May-18 4:51 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 13-May-18 | Market Sale | 6,164 | $5.09 | $31,368.60 | (49%) 12.67K to 6.51K | 29% |
31-May-18 4:51 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 13-May-18 | Exercise (in-the money or at-the-money) | 6,224 | $5.04 | $31,369.00 | 97% 6.45K to 12.67K | (29%) |